Dong Gyu Na1, Hye Sook Min2, Hunkyung Lee3, Jae-Kyung Won2, Hyo Bin Seo4, Ji-Hoon Kim5. 1. Department of Radiology, Human Medical Imaging and Intervention Center, Seoul, South Korea. 2. Department of Pathology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea. 3. Department of Pathology, Ewha Clinical Laboratory, Seoul, South Korea. 4. Department of Radiology, Seoul National University Hospital Kangnam Center, Seoul, South Korea. 5. Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Abstract
BACKGROUND: The role of repeat fine-needle aspiration (RFNA) or core needle biopsy (CNB) has not been established in nodules categorized as atypia/follicular lesion of undetermined significance (AUS/FLUS). OBJECTIVE: The purpose of this study was to retrospectively determine whether CNB is more useful for management decisions than RFNA at each subcategory of AUS/FLUS nodules. METHODS: This study included 158 AUS/FLUS nodules (≥1 cm) from 153 consecutive patients who underwent both RFNA and CNB. The AUS/FLUS nodules were subcategorized into nuclear atypia (NA) and follicular lesions with other atypia (FOA). The diagnostic results and rate of determined management by RFNA and CNB were compared at each subcategory. The diagnostic values of RFNA and CNB for malignancy were evaluated in nodules with final diagnoses. RESULTS: CNB showed a lower rate of AUS/FLUS diagnosis, higher rates of benign and follicular neoplasm or suspicious for a follicular neoplasm (FN/SFN) diagnoses (p ≤ 0.038), and marginally higher rates of malignant diagnosis than RFNA in the NA subcategory. CNB showed a higher rate of FN/SFN (p = 0.007) than RFNA in the FOA subcategory. CNB also demonstrated a higher rate of surgery decision than RFNA in both the NA subcategory (20.2 vs. 9.6%, p < 0.001) and FOA subcategory (20.8 vs. 5.6%, p = 0.007), and a higher rate of observation decision only in the NA subcategory (48.1 vs. 35.6%, p = 0.035). CNB demonstrated a higher diagnostic performance for malignancy overall in the nodules compared with RFNA. CONCLUSION: CNB may be more useful for management decisions than RFNA in both the NA and FOA subcategories, and has the potential to be a first-line alternative diagnostic tool in initially diagnosed AUS/FLUS nodules.
BACKGROUND: The role of repeat fine-needle aspiration (RFNA) or core needle biopsy (CNB) has not been established in nodules categorized as atypia/follicular lesion of undetermined significance (AUS/FLUS). OBJECTIVE: The purpose of this study was to retrospectively determine whether CNB is more useful for management decisions than RFNA at each subcategory of AUS/FLUS nodules. METHODS: This study included 158 AUS/FLUS nodules (≥1 cm) from 153 consecutive patients who underwent both RFNA and CNB. The AUS/FLUS nodules were subcategorized into nuclear atypia (NA) and follicular lesions with other atypia (FOA). The diagnostic results and rate of determined management by RFNA and CNB were compared at each subcategory. The diagnostic values of RFNA and CNB for malignancy were evaluated in nodules with final diagnoses. RESULTS: CNB showed a lower rate of AUS/FLUS diagnosis, higher rates of benign and follicular neoplasm or suspicious for a follicular neoplasm (FN/SFN) diagnoses (p ≤ 0.038), and marginally higher rates of malignant diagnosis than RFNA in the NA subcategory. CNB showed a higher rate of FN/SFN (p = 0.007) than RFNA in the FOA subcategory. CNB also demonstrated a higher rate of surgery decision than RFNA in both the NA subcategory (20.2 vs. 9.6%, p < 0.001) and FOA subcategory (20.8 vs. 5.6%, p = 0.007), and a higher rate of observation decision only in the NA subcategory (48.1 vs. 35.6%, p = 0.035). CNB demonstrated a higher diagnostic performance for malignancy overall in the nodules compared with RFNA. CONCLUSION: CNB may be more useful for management decisions than RFNA in both the NA and FOA subcategories, and has the potential to be a first-line alternative diagnostic tool in initially diagnosed AUS/FLUS nodules.
Authors: Martin H Luu; Andrew H Fischer; Thomas J Stockl; Latha Pisharodi; Christopher L Owens Journal: Acta Cytol Date: 2011-12-09 Impact factor: 2.319
Authors: Ra Gyoung Yoon; Jung Hwan Baek; Jeong Hyun Lee; Young Jun Choi; Min Ji Hong; Dong Eun Song; Jae Kyun Kim; Jong Ho Yoon; Won Bae Kim Journal: Thyroid Date: 2014-09-19 Impact factor: 6.568
Authors: Zubair W Baloch; Edmund S Cibas; Douglas P Clark; Lester J Layfield; Britt-Marie Ljung; Martha Bishop Pitman; Andrea Abati Journal: Cytojournal Date: 2008-04-07 Impact factor: 2.091
Authors: Young Hen Lee; Jung Hwan Baek; So Lyung Jung; Jin Young Kwak; Ji-hoon Kim; Jung Hee Shin Journal: Korean J Radiol Date: 2015-02-27 Impact factor: 3.500